HUTCHMED (China) Limited - ADR
HCM - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.41B
Close$
$18.74
34.5% upside
Current Fair Value
34.5% upsideUndervalued by 34.5% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $2.41 Billion |
|---|---|
| Enterprise Value | $2.40 Billion |
| Earnings per Share | $2.65 |
| Beta | 0.43 |
| Outstanding Shares | 173,168,080 |
Return
| Return on Equity | 1.42% |
|---|---|
| Return on Assets | 1.03% |
| Return on Invested Capital | -2.38% |
Valuation & Multiples
| P/E Ratio | 143.19 |
|---|---|
| PEG | -148.39 |
| Price to Sales | 4.64 |
| Price to Book Ratio | 1.99 |
| Enterprise Value to Revenue | 4.37 |
| Enterprise Value to EBIT | -69.02 |
| Enterprise Value to Net Income | 134 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.07 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 3, 2026
EPS Estimate
$0.15
Consensus analyst estimateRevenue Estimate
$306.40 M
Consensus analyst estimateNext Earnings Call
Expected Date
March 4, 2027
EPS Estimate
$0.21
Consensus analyst estimateRevenue Estimate
$329.08 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.16%▼ 2.33% |
|---|---|
| Total Invested | $4.15M▼ 91.09% |
| Investors Holding | 6▼ 50.00% |
About Hutchison China Meditech Ltd.
1,796 employees
CEO: Christian Hogg
HUTCHMED (China) Limited, a biopharmaceutical company established in 2000 and headquartered in Central, Hong Kong, focuses on the discovery, development, and commercialization of innovative targeted therapies and immunotherapies. The com...